
Waiting list rises after row over NHS figures
The backlog rose by 10,000 to 7.37 million as of the end of June, compared with the previous month, driven by an increase in the number of patients being referred for appointments.
It comes as experts revealed the NHS waiting list data was 'misleading' because it did not publish the number of 'unreported removals' – where patients who no longer need an appointment because of a variety of reasons have been deleted from the list.
The Nuffield Trust think tank's analysis revealed as many as 245,000 people per month were being taken off the waiting list through these 'validation processes', and highlighted that fewer patients were being treated than added to the backlog.
The Government said this only accounted for 15 per cent of the fall in the backlog since it took charge last July, with the waiting list down from 7.6 million on last July.
The NHS said it had treated more than 100,000 people in June, up 2 per cent on the year before, but 141,000 patients joined the waiting list.
The number of people waiting the longest also fell, with just 1,100 waiting more than 18 months.
Dr Becks Fisher, director of research and policy at the Nuffield Trust, said the figures remain 'stubbornly high at 7.37 million and the NHS is struggling to keep pace with demand'.
'But the reported numbers on the planned treatment waiting list only show part of the picture,' she said. 'Our new analysis shows that waiting list reductions in previous months are not wholly due to increases in appointments being delivered. In fact, the NHS is still treating fewer patients than are being referred.'
She added: 'We should be under no illusions that despite delivering more appointments, the NHS is still not meeting patient demand.
'The Health Secretary has praised 'record investment and fundamental NHS reform' as the reasons behind reductions in the waiting list earlier this year, but there are lingering background causes that go unmentioned.'
Wes Streeting, the Health Secretary, said the Government had gone beyond its promise to deliver two million more appointments.
'One year on, we have delivered almost an extra five million appointments. As a result, today's figures show that, despite record numbers of people coming forward for treatment, we are cutting waiting times, with the lowest number of patients waiting more than 18 weeks for treatment in three years,' he said.
Separate figures published by the NHS showed that 11,000 more appointments and procedures went ahead during junior – now called resident – doctor strikes last month, compared to last July's five-day walkout.
Mr Streeting will continue discussions with the British Medical Association throughout the summer in a bid to avert further industrial action.
The Health Secretary said the figures show the NHS 'was more resilient against last month's strike action than ever before'.
'We are getting on with the job of delivering progress in the face of strike action, and we will continue to put patients first,' he said.
Professor Meghana Pandit, NHS national medical director, said: 'It is very welcome news that the Resident Doctors Committee has returned to talks – and we hope this leads to a resolution that avoids further disruption for patients.'
Meanwhile, data on A&E wait times shows 76.4 per cent of patients were seen within four hours last month, up from 75.5 per cent in June.
The number of patients waiting 12 hours for a hospital bed fell to 35,467 from 38,683 a month earlier.
Despite this reduction, Dr Nick Murch, president of the Society for Acute Medicine, described the 12-hour wait figure as 'unacceptable'.
He said: 'Clinicians across the UK are reporting this week as one of the worst they have experienced, with no sign of the brief respite seen in the immediate aftermath of recent strike action, yet there remains no tangible and immediate action to address urgent workforce and capacity issues.
'Sadly, instead, recent commentary and reporting suggests a growing reliance on selective or misleading interpretations of NHS data, as highlighted this week in analysis by the Nuffield Trust, which calls into question claims the NHS is being turned around.'
Mr Tim Mitchell, president of the Royal College of Surgeons of England, said the waiting list rise was 'likely down to seasonal ebbs and flows'.
'However, as analysis published this week shows, the drop in waiting list numbers we've seen prior to this month doesn't necessarily mean more patients are being treated,' he said.
'The Government should be honest that a significant part of recent reductions reflects validation exercises rather than increased surgical activity.
'Ultimately, only further investment to expand the NHS' capacity will deliver substantial reductions in waiting times,' he added.
Helen Morgan MP, the Liberal Democrat health spokesman, said: 'This Government is doing no better than treading water on getting the waiting list down.
'These figures will add salt to the wounds of [Wednesday's] news that Labour appear to be cooking the books – boasting of treating phantom patients who have in fact died, moved or desperately had to seek treatment elsewhere.'

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
7 minutes ago
- The Independent
Warning over ‘life-threatening' fake Ozempic jabs sold by bogus online pharmacies
Warnings have been issued over fake weight loss jabs that could be 'life-threatening' after thousands of fraudulent online pharmacies were uncovered. Fake versions of Ozempic, a popular brand of weight loss jab, were being sold for as little as £13.70 per dose, along with counterfeit versions of other brands, including Rybelsus and Metformin pills, being offered from 24p. The UK's medicines regulator said taking bogus medications could not only make people ill, but in some cases could be fatal. Researchers from cybersecurity company Gen, who conducted the research, warned of the 'dangerous' threat of the global scam involving more than 5,000 fake pharmacy sites this year, which they say are being run by criminal networks. It comes amid the rapid rise of weight-loss medication in the UK - with around 1.5 million people, 4 per cent of households, currently using them. Gen also found fake Viagra, a medicine used to treat erection issues, and unregulated fertility pills being sold. The company said lab tests found no active ingredient in a third of the drugs tested. Andy Morling, deputy director of criminal enforcement at the Medicines and Healthcare products Regulatory Agency (MHRA), told The Independent: 'Buying medicines from illegal suppliers significantly increases the risk of receiving products that are either falsified or not licensed for use in the UK. Products purchased in this way will not meet the MHRA's strict quality and safety standards, and taking such medicines may put one's health at risk.' 'Fake prescription and over-the-counter medicines not only fail to work but can also make you sick. Even worse, in the most severe cases, they may contain dangerous ingredients, potentially leading to death,' the regulator added. The researchers warned that the 'alarmingly' polished websites, complete with bogus customer service information, detailed product pages, and looked similar to legitimate online pharmacies. But many were detected as fakes because they used AI to create reviews, health blogs, live chat support and manipulated search results. As well as the health implications, the researchers said UK customers risked their details and identity being stolen by the sites. Siggi Stefnission, cyber safety chief technology officer at Gen, warned: 'Purchasing pharmaceuticals from untrusted online retailers is a serious danger, both to individual health and to someone's digital safety. 'From a public health perspective, counterfeit or unregulated drugs can be ineffective or even life-threatening. It's critical that consumers only use licensed, reputable online pharmacies to protect themselves from cybercrime and potential physical harm.' The popularity of weight-loss jabs has soared in the past year, with the NHS 's top doctor, Sir Stephen Powis, saying they could soon become among the most commonly used drugs. Both Ozempic and Rybelsus, which have the active ingredient semaglutide, are not licensed as a weight loss treatment. Instead they are designed to treat people with type 2 diabetes but both are sometimes prescribed off-label to treat weight loss. However, popular weight loss jabs Wegovy, which has the same active ingredient, and Mounjaro, which uses the active ingredient tirzepatide, are both licensed in the UK for the treatment of weight loss. Gen explained that criminals are taking advantage of people looking for a fast and discreet way to get high-demand weight loss treatment, among other medications that are often sought quickly, privately, or at a lower cost. Alongside the vast network of more than 5,000 web domains selling the in-demand drugs fraudulently, Gen said, this year alone, it has already blocked 1 million attacks coming from these sites against unsuspecting online shoppers. Laura Wilson, director at Royal Pharmaceutical Society, said fake and illegal online pharmacies 'are a growing threat to patient safety'. She explained that fraudulent medicines may be out of date, substandard or contain 'dangerous' substances. Gen said its team is currently working on testing fake medications to work out what exactly they are made of. The company advised consumers to watch out for low-cost offers for prescription-only drugs, missing contact information, requests for cryptocurrency payments, unsecured checkout processes, and prompts for sensitive personal, medical, or financial data. Novo Nordisk, the company that makes Ozempic and Rybelsus, said it was aware that counterfeit Ozempic products are being sold in the UK and is working with health authorities, including the MHRA, to investigate the 'critical issue'. It advised people to examine packaging and pens closely before using them. Mr Morling said the MHRA is cracking down on the issue of fake medicines and pharmacies, with offenders potentially facing criminal investigation and prosecution.


BBC News
38 minutes ago
- BBC News
Innovative device at Royal Surrey improves prostate cancer result
A hospital in Surrey says it is the first NHS trust in the UK to use a "revolutionary" new device that improves prostate cancer surgery and reduces the need for Histolog Scanner allows surgeons at Royal Surrey County Hospital to assess the prostate for cancerous tissue in real-time during surgery rather than wait for post-operation trust says the technology enables surgeons to remove additional tissue if required, potentially reducing the risk of leaving behind cancerous cells. Wissam Abou-Chedid, consultant urological surgeon, said: "This technology marks a real leap forward in prostate cancer surgery." He said: "For the first time, we can assess tissue in real time while the patient is still on the operating table – allowing us to make immediate, informed decisions that improve cancer control without putting quality of life at risk."It means fewer patients needing radiotherapy afterwards, and more men retaining their continence and sexual function."Royal Surrey's urology clinical director, Dimitrios Moschonas, said the scanner strengthens the hospital's reputation as a national leader in prostate cancer treatment and robotic surgery."As the highest-volume single-site centre for robotic prostatectomy in the UK, Royal Surrey continues to lead with pioneering initiatives," he said. In May 2023, Royal Surrey's urology team set a record, performing 12 robotic prostatectomies in a single day. In August, the team was shortlisted for an HSJ award for its catheter scheme to assist prostate cancer patients following robotic surgery. Patients are taught how to safely remove their own catheters at home, avoiding return trips to the hospital.


Scotsman
an hour ago
- Scotsman
What you need to be aware of when you're taking weight loss jabs
Around 1.5 million people in the UK use weight loss treatments 💉 Sign up to our daily newsletter Sign up Thank you for signing up! Did you know with a Digital Subscription to Edinburgh News, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, loyalty rewards and much more. Learn More Sorry, there seem to be some issues. Please try again later. Submitting... An estimated 1.5 million people in the UK use weight loss medications. GPs were given the green light to prescribe weight loss jabs in June. A pharmacist has revealed what you need to be aware of when starting them. A leading pharmacist has revealed exactly what to expect after starting weight loss jabs. An estimated 1.5 million people in the UK use weight-loss treatments, though that number is expected to rise after GPs were given the green light to prescribe them in June this year. Advertisement Hide Ad Advertisement Hide Ad Weight loss treatments are now available across the UK through the NHS, although the majority of users (estimated at 1.4 million) still access them privately via online pharmacies. This has prompted calls from Well Pharmacy's Head of Weight Management Services Mital Thakrar, to urge users to have all the facts in front of them before starting their weight-loss journey. Mr Thakrar said: 'Weight-loss treatments are increasing in popularity and the benefits are plain to see. A recent trial looking at Brit's weight loss after using weight-loss treatments showed over eight in 10 people lost at least 5% of their weight, and around half lost 15% or more. 'The more patients know about what to expect and how to prevent and or manage side effects, the smoother their journey will be.' Advertisement Hide Ad Advertisement Hide Ad An estimated 1.5 million people in the UK use weight loss treatments. | Pexels, MART PRODUCTION What to expect when starting weight loss injections? When you start weight loss treatment, the medications are likely to leave you feeling fuller faster, and you may have less interest in food. This is because the drugs delay your stomach from emptying, which can leave you feeling fuller for longer. Mr Thakrar said: 'You may feel nauseous or might even vomit. This is very common in the early days and will pass. One way of easing these symptoms is by eating smaller meals and avoiding fatty or spicy foods.' Other common side effects include constipation and diarrhoea, which can be managed by ensuring you are drinking water regularly. Fibre supplements or stool softeners are also helpful in easing constipation symptoms. There are also reports of indigestion or heartburn. Avoid lying down after eating, or speak to your pharmacist about antacids that can help by neutralising excess stomach acids. Advertisement Hide Ad Advertisement Hide Ad Mr Thakrar added: 'Some users report tiredness and headaches, but this is often temporary and improves with time. My most important piece of advice would be to get expert advice from a trained healthcare professional when you start weight loss treatments.' When will I start losing weight? Weight loss will start slowly, peaking between three to six months as your body adjusts. Mr Thakrar explains: 'Initially, most weight loss is water and appetite-related. Peak fat loss comes between months three and six, when results should be visible. It's after six months that things slow down, unless you've changed your habits, like being more active, and eating more healthily.' Advertisement Hide Ad Advertisement Hide Ad What can I do to increase my weight loss? Weight loss treatments enhance, but don't replace lifestyle changes. Mr Thakrar, explains that it's important to take diet and exercise into consideration as part of your overall weight loss plan. When should I seek medical help? Some side effects indicate you should seek medical help from your pharmacist or doctor immediately. This includes persistent vomiting, intense abdominal pain, or ongoing feelings of nausea. Mr Thakrar said: 'This could be early signs of pancreatitis, which is a serious condition where an organ called the pancreas becomes inflamed. Many people with acute pancreatitis recover within a week with treatment and rest. But severe cases can lead to complications like pancreatic necrosis (tissue death), infection, pseudocysts (fluid-filled sacs), and organ failure.' If you are having difficulty breathing, swallowing, or a rash or swelling, this could be a sign of an allergic reaction and requires urgent medical help. Advertisement Hide Ad Advertisement Hide Ad Mr Thakrar said: 'These might be signs of a serious allergic reaction (called anaphylaxis) or airway swelling, both of which can become life-threatening very quickly. 'Even though these reactions are rare with weight-loss treatments, they can still happen, especially when starting a new medication, so it's important to be vigilant and act quickly if you have any concerns. If it's a serious medical emergency, call 999' Will weight loss medications work long-term? Most people lose at least 5% of their body weight when following weight loss treatment, with around half losing 15% or more. Mr Thakrar said: 'To put it into perspective, if you weigh 100 kg, a 15% loss is around 15 kg (about 2.5 stone), and if you weigh 85 kg, a 10% loss is 8.5 kg (just over a stone)'. Advertisement Hide Ad Advertisement Hide Ad However, for the treatment to remain effective, you must combine weight loss treatment with healthy habits like eating well and exercising more to see long-term improvements. You can find out more about how to follow a healthy lifestyle and tips for weight loss at NHS Better Health.